N. Galiè, M. Humbert, and J. L. Vachiery, ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Respir J, vol.46, issue.4, pp.903-975, 2015.

G. Simonneau, M. A. Gatzoulis, and I. Adatia, Updated clinical classification of pulmonary hypertension, J Am Coll Cardiol, vol.62, pp.34-41, 1925.

M. Humbert, O. Sitbon, and A. Chaouat, Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era, Circulation, vol.122, issue.2, pp.156-163, 2010.

O. Sitbon, R. L. Benza, and D. B. Badesch, Validation of two predictive models for survival in pulmonary arterial hypertension, Eur Respir J, vol.46, issue.1, pp.152-164, 2015.

F. Soubrier, W. K. Chung, and R. Machado, Genetics and genomics of pulmonary arterial hypertension, J Am Coll Cardiol, vol.62, pp.13-21, 1925.
URL : https://hal.archives-ouvertes.fr/hal-02137830

M. Rabinovitch, C. Guignabert, M. Humbert, and M. R. Nicolls, Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circ Res, vol.115, issue.1, pp.165-175, 2014.

P. M. Hassoun, L. Mouthon, and J. A. Barbera, Inflammation, growth factors, and pulmonary vascular remodeling, J Am Coll Cardiol, vol.54, issue.1, pp.10-19, 2009.

P. Dorfmüller, F. Perros, K. Balabanian, and M. Humbert, Inflammation in pulmonary arterial hypertension, Eur Respir J, vol.22, issue.2, pp.358-363, 2003.

F. Perros, P. Dorfmüller, and D. Montani, Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.185, issue.3, pp.311-321, 2012.

N. F. Voelkel, J. Gomez-arroyo, A. Abbate, H. J. Bogaard, and M. R. Nicolls, Pathobiology of pulmonary arterial hypertension and right ventricular failure, Eur Respir J, vol.40, issue.6, pp.1555-1565, 2012.

E. Soon, A. Crosby, and M. Southwood, Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.192, issue.7, pp.859-872, 2015.

E. Stacher, B. B. Graham, and J. M. Hunt, Modern age pathology of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.186, issue.3, pp.261-272, 2012.

K. Wing and S. Sakaguchi, Regulatory T cells exert checks and balances on self tolerance and autoimmunity, Nat Immunol, vol.11, issue.1, pp.7-13, 2010.

M. M. Tiemessen, A. L. Jagger, H. G. Evans, M. J. Van-herwijnen, S. John et al., CD4þCD25þFoxp3þ regulatory T cells induce alternative activation of human monocytes/macrophages, Proc Natl Acad Sci, vol.104, issue.49, pp.19446-19451, 2007.

G. Bussone, M. C. Tamby, and C. Calzas, IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction, Ann Rheum Dis, vol.71, issue.4, pp.596-605, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00785898

H. Dib, M. C. Tamby, and G. Bussone, Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma, Eur Respir J, vol.39, issue.6, pp.1405-1414, 2012.

M. C. Tamby, Y. Chanseaud, and M. Humbert, Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension, Thorax, vol.60, issue.9, pp.765-772, 2005.

B. Terrier, M. C. Tamby, and L. Camoin, Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.177, issue.10, pp.1128-1134, 2008.

S. J. Arends, J. Damoiseaux, and A. Duijvestijn, Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.35, issue.4, pp.923-925, 2010.

M. Karmochkine, P. Cacoub, and R. Dorent, High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension, J Rheumatol, vol.23, issue.2, pp.286-290, 1996.

A. Huertas, F. Perros, and L. Tu, Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay, Circulation, vol.129, issue.12, pp.1332-1340, 2014.

R. Tamosiuniene, W. Tian, and G. Dhillon, Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension, Circ Res, vol.109, issue.8, pp.867-879, 2011.

W. Tian, X. Jiang, and R. Tamosiuniene, Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension, Sci Transl Med, vol.5, pp.200-117, 0200.

A. Huertas, L. Tu, and N. Gambaryan, Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension, Eur Respir J, vol.40, issue.4, pp.895-904, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00913076

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary arterial hypertension in France: results from a national registry, Am J Respir Crit Care Med, vol.173, issue.9, pp.1023-1030, 2006.

Y. Song, J. E. Jones, H. Beppu, J. F. Keaney, . Jr et al., Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice, Circulation, vol.112, issue.4, pp.553-562, 2005.

H. Sawada, T. Saito, and N. P. Nickel, Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension, J Exp Med, vol.211, issue.2, pp.263-280, 2014.

K. H. Hong, Y. J. Lee, and E. Lee, Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension, Circulation, vol.118, issue.7, pp.722-730, 2008.

L. Tu, F. S. De-man, and B. Girerd, A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents, Am J Respir Crit Care Med, vol.186, issue.7, pp.666-676, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00905191

J. R. Pallandre, E. Brillard, and G. Créhange, Role of STAT3 in CD4þCD25þFOXP3þ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity, J Immunol, vol.179, issue.11, pp.7593-7604, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00479712

S. Ulrich, M. R. Nicolls, L. Taraseviciene, R. Speich, and N. Voelkel, Increased regulatory and decreased CD8þ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension, Respiration, vol.75, issue.3, pp.272-280, 2008.

A. Chaudhry, R. M. Samstein, and P. Treuting, Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation, Immunity, vol.34, issue.4, pp.566-578, 2011.

M. A. Gavin, T. R. Torgerson, and E. Houston, Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development, Proc Natl Acad Sci, vol.103, issue.17, pp.6659-6664, 2006.

J. Wang, A. Ioan-facsinay, E. I. Van-der-voort, T. W. Huizinga, and R. E. Toes, Transient expression of FOXP3 in human activated nonregulatory CD4þ T cells

, Eur J Immunol, vol.37, issue.1, pp.129-138, 2007.

A. Huertas, L. Tu, and R. Thuillet, Leptin signalling system as a target for pulmonary arterial hypertension therapy, Eur Respir J, vol.45, issue.4, pp.1066-1080, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02579431

J. L. Cracowski, F. Chabot, and J. Labarère, Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension, Eur Respir J, vol.43, issue.3, pp.915-917, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02271055

G. A. Heresi, M. Aytekin, J. P. Hammel, S. Wang, S. Chatterjee et al., Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension, Eur Respir J, vol.4, issue.3, pp.912-914, 2014.

E. Soon, A. M. Holmes, and C. M. Treacy, Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension, Circulation, vol.122, issue.9, pp.920-927, 2010.

M. Humbert, G. Monti, and F. Brenot, Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension, Am J Respir Crit Care Med, vol.151, issue.5, pp.1628-1631, 1995.

F. Perros, P. Dorfmüller, and R. Souza, Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension, Eur Respir J, vol.29, issue.3, pp.462-468, 2007.

R. M. Tuder, B. Groves, D. B. Badesch, and N. F. Voelkel, Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension, Am J Pathol, vol.144, issue.2, pp.275-285, 1994.

R. A. Isern, M. Yaneva, and E. Weiner, Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku, Am J Med, vol.93, issue.3, pp.307-312, 1992.

A. Hautefort, B. Girerd, and D. Montani, T-helper 17 cell polarization in pulmonary arterial hypertension, Chest, vol.147, issue.6, pp.1610-1620, 2015.

G. Frühbeck, Intracellular signalling pathways activated by leptin, Biochem J, vol.393, pp.7-20, 2006.

L. Cava, A. Matarese, and G. , The weight of leptin in immunity, Nat Rev Immunol, vol.4, issue.5, pp.371-379, 2004.

I. Shalev, M. Schmelzle, S. C. Robson, and G. Levy, Making sense of regulatory T cell suppressive function, Semin Immunol, vol.23, issue.4, pp.282-292, 2011.

M. O. Li and R. A. Flavell, TGF-beta: a master of all T cell trades, Cell, vol.134, issue.3, pp.392-404, 2008.

C. E. Ruby, M. A. Yates, and D. Hirschhorn-cymerman, Cutting edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right, J Immunol, vol.183, issue.8, pp.4853-4857, 2009.

E. Lam, S. H. Choi, T. K. Pareek, B. G. Kim, and J. J. Letterio, Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727, Mol Immunol, vol.67, issue.2, pp.317-324, 2015.

L. Dewachter, S. Adnot, and C. Guignabert, Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension, Eur Respir J, vol.34, issue.5, pp.1100-1110, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00433927

M. Miyata, F. Sakuma, M. Ito, H. Ohira, Y. Sato et al., Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration, Int Arch Allergy Immunol, vol.121, issue.3, pp.246-252, 2000.

L. Taraseviciene-stewart, M. R. Nicolls, and D. Kraskauskas, Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling

, journal.publications.chestnet.org, vol.175, issue.12, pp.1280-1289, 2007.